Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

240.54 -0.96 (-0.40%)
Streaming Delayed Price Updated: 10:57 AM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 491,104
Open 241.43
Bid (Size) 240.51 (1)
Ask (Size) 240.56 (3)
Prev. Close 241.50
Today's Range 240.50 - 242.40
52wk Range 223.30 - 296.67
Shares Outstanding N/A
Dividend Yield 2.93%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
1 Dividend Growth Stock to Buy Hand Over Fist
Investing in dividend stocks, particularly those that raise their payouts regularly, can pay off massively in time. 
Via The Motley Fool
Amgen's Debt Overview
 
Via Benzinga

Performance

YTD
-8.07%
-8.07%
1 Month
+3.83%
+3.83%
3 Month
-8.60%
-8.60%
6 Month
+5.31%
+5.31%
1 Year
-0.84%
-0.84%

More News

Read More
A Look Into Amgen Inc's Price Over Earnings
Via Benzinga
Amgen Options Traders Betting On Stock Rising This Much By April Expiration
Via Benzinga
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
Via The Motley Fool
The Government Move That Could Drive Obesity Drugs — And Lilly, Novo Shares
Via Investor's Business Daily
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run
Via The Motley Fool
Looking At Amgen's Recent Unusual Options Activity
Via Benzinga
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
Viking Therapeutics' Initial VK2735 'Data Resoundingly Beat Expectations,' Analyst Says
Via Benzinga
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Via MarketBeat
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amgen Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
Via Investor's Business Daily
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc. (AMGN)
From Glancy Prongay & Murray LLP
Via Business Wire
Nvidia's Artificial Intelligence Market Strategy Impresses Wall Street
Via Investor's Business Daily
Amgen Inc. (AMGN) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Amgen Inc.
From Robbins LLP
Via Business Wire
Nvidia Ramps Up Artificial Intelligence Offerings Amid AI's 'iPhone Moment'
Via Investor's Business Daily
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc. (AMGN)
From Law Offices of Howard G. Smith
Via Business Wire
These Are The Top 3 Large Caps For Yield And Dividend Growth
Via MarketBeat
Topics Economy
Exposures Interest Rates
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now
Via The Motley Fool
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (NASDAQ: AMGN)
From Bernstein Liebhard LLP
Via Globe NewsWire
ROSEN, A LEADING LAW FIRM, Encourages Amgen Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.